First Department of Internal Medicine, University of Szeged, Szeged, Hungary.
Digestion. 2012;85(1):40-6. doi: 10.1159/000333083. Epub 2011 Dec 14.
BACKGROUND/AIMS: Defective epithelial barrier has been implicated in the pathogenesis of irritable bowel syndrome (IBS) and inflammatory bowel diseases. The aim of this study was to investigate gut permeability in patients with inactive ulcerative colitis (UC) and in patients with IBS.
IBS patients of the diarrhea-predominant (IBS-D) and of the constipation-predominant subgroup (IBS-C), patients with inactive UC and healthy subjects were enrolled. Gut permeability was evaluated by measuring 24-hour urine excretion of orally administered (51)Cr-EDTA. Clinical symptoms were evaluated in IBS-D patients and correlated to colonic permeability.
There was a significant decrease in the proximal small intestinal permeability in IBS-C patients compared to controls (0.26 ± 0.05 vs. 0.63 ± 0.1%; p < 0.05). Distal small intestinal permeability showed no significant difference in the studied group of patients compared to controls. Colonic permeability of IBS-D and inactive UC patients was significantly increased compared to controls (2.68 ± 0.35 and 3.74 ± 0.49 vs. 1.04 ± 0.18%; p < 0.05, p < 0.001). Colonic permeability of IBS-D patients correlated with stool frequency.
Elevated gut permeability is localized to the colon both in IBS-D and in inactive UC patients.
背景/目的:肠上皮屏障功能障碍与肠易激综合征(IBS)和炎症性肠病的发病机制有关。本研究旨在探讨活动期溃疡性结肠炎(UC)患者和 IBS 患者的肠道通透性。
纳入 IBS 腹泻型(IBS-D)和便秘型(IBS-C)患者、活动期 UC 患者和健康对照者。通过测量口服(51)Cr-EDTA 后 24 小时尿液排泄来评估肠道通透性。在 IBS-D 患者中评估临床症状,并与结肠通透性相关。
与对照组相比,IBS-C 患者近端小肠通透性显著降低(0.26 ± 0.05 比 0.63 ± 0.1%;p < 0.05)。研究组患者的远端小肠通透性与对照组无显著差异。IBS-D 和活动期 UC 患者的结肠通透性明显高于对照组(2.68 ± 0.35 和 3.74 ± 0.49 比 1.04 ± 0.18%;p < 0.05,p < 0.001)。IBS-D 患者的结肠通透性与粪便频率相关。
IBS-D 和活动期 UC 患者的肠道通透性均局限于结肠。